BNP Paribas Financial Markets’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.5K | Sell |
3,009
-5,407
| -64% | -$4.49K | ﹤0.01% | 4218 |
|
|
2025
Q1 | $5.66K | Sell |
8,416
-7,567
| -47% | -$5.09K | ﹤0.01% | 3997 |
|
|
2024
Q4 | $15.1K | Sell |
15,983
-9,285
| -37% | -$8.77K | ﹤0.01% | 3920 |
|
|
2024
Q3 | $38.4K | Buy |
25,268
+5,809
| +30% | +$8.83K | ﹤0.01% | 2940 |
|
|
2024
Q2 | $23.2K | Buy |
19,459
+14,904
| +327% | +$17.7K | ﹤0.01% | 2943 |
|
|
2024
Q1 | $8.2K | Hold |
4,555
| – | – | ﹤0.01% | 3035 |
|
|
2023
Q4 | $4.01K | Hold |
4,555
| – | – | ﹤0.01% | 3051 |
|
|
2023
Q3 | $3.36K | Hold |
4,555
| – | – | ﹤0.01% | 3003 |
|
|
2023
Q2 | $5.74K | Hold |
4,555
| – | – | ﹤0.01% | 3039 |
|
|
2023
Q1 | $3.3K | Sell |
4,555
-5,063
| -53% | -$3.67K | ﹤0.01% | 2977 |
|
|
2022
Q4 | $5.08K | Hold |
9,618
| – | – | ﹤0.01% | 3001 |
|
|
2022
Q3 | $8.02K | Sell |
9,618
-8,609
| -47% | -$7.17K | ﹤0.01% | 3490 |
|
|
2022
Q2 | $19.9K | Sell |
18,227
-14,835
| -45% | -$16.2K | ﹤0.01% | 3058 |
|
|
2022
Q1 | $41.3K | Sell |
33,062
-18,064
| -35% | -$22.6K | ﹤0.01% | 3019 |
|
|
2021
Q4 | $81.8K | Buy |
51,126
+23,986
| +88% | +$38.4K | ﹤0.01% | 3008 |
|
|
2021
Q3 | $88.5K | Buy |
27,140
+16,657
| +159% | +$54.3K | ﹤0.01% | 2727 |
|
|
2021
Q2 | $66.3K | Buy |
+10,483
| New | +$66.3K | ﹤0.01% | 2572 |
|